Latvia vs Mus: Diphtheria tetanus toxoid and pertussis third-dose (DTP3)
Latvia
99.0%
in 2025
Mus
96.0%
in 2025
Latvia rank
1st
Mus rank
1st
Diphtheria tetanus toxoid and pertussis third-dose (DTP3) over time
- Latvia
- Mus
How they compare
Latvia currently reports 99.0% against 96.0% in Mus, a difference of 3.0%.
The two have swapped places 8 times across 26 shared years of data; in 2000 it was Latvia ahead.
Latvia ranks 1st and Mus ranks 1st of 194 countries.
Across the 3 decades both report, Latvia averaged higher in 2 and Mus in 1.
Head to head by decade
| Decade | Latvia | Mus | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 96.4% | 95.4% | 1.0% | Latvia |
| 2010s | 94.6% | 97.0% | 2.4% | Mus |
| 2020s | 97.0% | 95.0% | 2.0% | Latvia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher diphtheria tetanus toxoid and pertussis third-dose (dtp3), Latvia or Mus?
- Latvia, at 99.0% against 96.0% in Mus as of 2025.
- What is the difference in diphtheria tetanus toxoid and pertussis third-dose (dtp3) between Latvia and Mus?
- 3.0%, with Latvia ahead.
- How many years of comparable data are there for Latvia and Mus?
- 26 years are reported by both, from 2000 to 2025.
- How do Latvia and Mus rank globally for diphtheria tetanus toxoid and pertussis third-dose (dtp3)?
- Latvia ranks 1st and Mus ranks 1st of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Diphtheria tetanus toxoid and pertussis third-dose (DTP3) immunization coverage among 1-year-olds (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.